RebeccaRThomasMD

Oncology • Minneapolis, MN

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology

Medical Oncologist

Join to view full profile

Dr. Thomas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Thomas' full profile

Already have an account?

Office
Minneapolis
Minneapolis, MN 55422
Is this information wrong?

Education & Training

DukeMasters of Health Sciences in Clinical Research, Clinical Research, 2006
National Cancer InstituteResearch Fellow, 2001 - 2002
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
Hennepin HealthcareResidency, Internal Medicine, 1995 - 1998
Medical College of WisconsinClass of 1995

Certifications & Licensure

MN State Medical License 1998 - 2024
IL State Medical License 2003 - 2008
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

16 citations
The clinical development of 9-aminocamptothecin.
Chris H. Takimoto, Rebecca R. Thomas> ;Annals of the New York Academy of Sciences. 2006 Jan 25
113 citations
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer
Gregory D. Leonard, Maurice A. Wright, Mary G. Quinn, Suzanne Fioravanti, Nancy Harold, Barbara Schuler, Rebecca R. Thomas, Jean L. Grem> ;BMC Cancer. 2005 Sep 16
201 citations
Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.
Jean L. Grem, Geraldine Morrison, Xiao Du Guo, Elizabeth B. Agnew, Chris H. Takimoto, Rebecca R. Thomas, Eva Szabo, Louise Grochow, Frank Grollman, J. Michael Hamilton...> ;Journal of Clinical Oncology. 2005 Mar 20
17 citations
New targeted therapies in gastrointestinal cancers.
Sharlene Gill, Rebecca R Thomas, Richard M. Goldberg> ;Current Treatment Options in Oncology. 2003 Oct 1
83 citations
Hypersensitivity and idiosyncratic reactions to oxaliplatin
Rebecca R. Thomas, G R N Mary Quinn, R N Barbara Schuler, Jean L. Grem> ;Cancer. 2003 May 1
14 citations
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule.
Xiao Du Guo, Nancy Harold, M. Wasif Saif, Barbara Schuler, Eva Szabo, J. Michael Hamilton, Brian P. Monahan, Mary G. Quinn, Janet Cliatt, Diana Nguyen, Frank Grollman,...> ;Cancer Chemotherapy and Pharmacology. 2003 Apr 18
13 citations
Cardiac Toxicity Associated with Capecitabine Therapy
M. Wasif Saif, Mary G. Quinn, Rebecca R. Thomas, Aaron Ernst, Jean L. Grem> ;Acta Oncologica. 2003 Jan 1
214 citations
Acute oxaliplatin-induced peripheral nerve hyperexcitability.
Richard H Wilson, Tanya Lehky, Rebecca R Thomas, Mary G Quinn, Mary Kay Floeter, Jean L Grem> ;Journal of Clinical Oncology. 2002 Apr 1
11 citations
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients.
Rebecca R. Thomas, William L. Dahut, Nancy Harold, Jean L. Grem, Brian P. Monahan, Michael Liang, Roger A. Band, Jeff Cottrell, Victor Llorens, Judith A. Smith, Willia...> ;Cancer Chemotherapy and Pharmacology. 2001 Sep 1
Join now to see all